Subtopic Deep Dive

← Atherosclerosis and Cardiovascular Diseases

Dendritic Cells in Atherosclerosis
Research Guide

What is Dendritic Cells in Atherosclerosis?

Dendritic cells in atherosclerosis are antigen-presenting immune cells that mature in vascular plaques, present antigens to T cells, and drive adaptive immunity during plaque inflammation and progression.

Research examines dendritic cell recruitment to atherosclerotic lesions via chemokine receptors like CCR2 and CX3CR1, their role in T-cell activation, and impact on plaque stability (Hansson et al., 2002; 1023 citations). Studies use depletion models to link DC activity to accelerated atherogenesis. Over 10 key papers from 2002-2022 highlight DC-monocyte interactions in lesion formation.

Curated Papers

Key Challenges

Why It Matters

Dendritic cells amplify adaptive immune responses in plaques, promoting T-cell infiltration that exacerbates inflammation and plaque vulnerability (Hansson et al., 2002; Frostegård, 2013). Targeting DC maturation offers therapies to modulate immunity in cardiovascular disease, as seen in monocyte subset studies linking CCR2+ cells to plaque accumulation (Tacke et al., 2007; 1289 citations; Świrski et al., 2007; 1246 citations). This bridges innate and adaptive immunity, informing immunotherapies for atherosclerosis prevention.

Key Research Challenges

DC Subset Heterogeneity

Distinguishing pro- vs anti-atherogenic dendritic cell subsets remains difficult due to overlapping monocyte-DC markers like Ly-6C and CX3CR1 (Tacke et al., 2007). Single-cell profiling is needed to resolve functional diversity in plaques. Current models underrepresent human DC variations.

Antigen Presentation Mechanisms

Mechanisms by which DCs present oxidized LDL or apoptotic debris to T cells in subendothelial spaces are unclear (Tabas et al., 2007; 1361 citations). Plaque hypoxia alters DC maturation signals. In vivo tracking of antigen-specific DC-T interactions lacks precision.

Therapeutic DC Depletion

DC depletion models show reduced plaque progression but risk systemic immunosuppression (Hansson et al., 2002). Translating mouse findings to human trials faces chemokine receptor redundancy challenges (Tacke et al., 2007). Long-term effects on plaque stability are unproven.

Essential Papers

Subendothelial Lipoprotein Retention as the Initiating Process in Atherosclerosis

Ira Tabas, Kevin Jon Williams, Jan Borén · 2007 · Circulation · 1.4K citations

The key initiating process in atherogenesis is the subendothelial retention of apolipoprotein B–containing lipoproteins. Local biological responses to these retained lipoproteins, including a chron...

Atherosclerotic Plaque Progression and Vulnerability to Rupture

Renu Virmani, Frank D. Kolodgie, Allen Burke et al. · 2005 · Arteriosclerosis Thrombosis and Vascular Biology · 1.3K citations

Observational studies of necrotic core progression identify intraplaque hemorrhage as a critical factor in atherosclerotic plaque growth and destabilization. The rapid accumulation of erythrocyte m...

Monocyte subsets differentially employ CCR2, CCR5, and CX3CR1 to accumulate within atherosclerotic plaques

Frank Tacke, David Álvarez, Theodore Kaplan et al. · 2007 · Journal of Clinical Investigation · 1.3K citations

Monocytes participate critically in atherosclerosis. There are 2 major subsets expressing different chemokine receptor patterns: CCR2(+)CX3CR1(+)Ly-6C(hi) and CCR2(-)CX3CR1(++)Ly-6C(lo) monocytes. ...

Ly-6Chi monocytes dominate hypercholesterolemia-associated monocytosis and give rise to macrophages in atheromata

Filip K. Świrski, Peter Libby, Elena Aïkawa et al. · 2007 · Journal of Clinical Investigation · 1.2K citations

Macrophage accumulation participates decisively in the development and exacerbation of atherosclerosis. Circulating monocytes, the precursors of macrophages, display heterogeneity in mice and human...

Age and Age-Related Diseases: Role of Inflammation Triggers and Cytokines

Irene Maeve Rea, David S. Gibson, Victoria McGilligan et al. · 2018 · Frontiers in Immunology · 1.2K citations

Cytokine dysregulation is believed to play a key role in the remodeling of the immune system at older age, with evidence pointing to an inability to fine-control systemic inflammation, which seems ...

Netting Neutrophils Induce Endothelial Damage, Infiltrate Tissues, and Expose Immunostimulatory Molecules in Systemic Lupus Erythematosus

Eneida C. Villanueva, Srilakshmi Yalavarthi, Céline C. Berthier et al. · 2011 · The Journal of Immunology · 1.2K citations

Abstract An abnormal neutrophil subset has been identified in the PBMC fractions from lupus patients. We have proposed that these low-density granulocytes (LDGs) play an important role in lupus pat...

Innate and Adaptive Immunity in the Pathogenesis of Atherosclerosis

Göran K. Hansson, Peter Libby, Uwe Schönbeck et al. · 2002 · Circulation Research · 1.0K citations

This review considers critically the evidence for the involvement of mediators of innate and acquired immunity in various stages of atherosclerosis. Rapidly mobilized arms of innate immunity, inclu...

Reading Guide

Foundational Papers

Start with Hansson et al. (2002; Circulation Research, 1023 citations) for innate-adaptive immunity framework, then Tabas et al. (2007; Circulation, 1361 citations) on lipoprotein retention triggering DC responses, followed by Tacke et al. (2007; JCI, 1289 citations) and Świrski et al. (2007; JCI, 1246 citations) for monocyte-DC plaque dynamics.

Recent Advances

Study Frostegård (2013; BMC Medicine, 1015 citations) for immunity overview, Tabas et al. (2015; JCB, 976 citations) for cellular biology updates, and Kong et al. (2022; Signal Transduction and Targeted Therapy, 966 citations) for inflammation signaling in DC contexts.

Core Methods

Core techniques include chemokine receptor knockout mice (CCR2/CX3CR1), Ly-6C subset sorting via flow cytometry, clodronate-mediated depletion, and plaque immunohistochemistry for DC markers (Tacke et al., 2007; Świrski et al., 2007).

How PapersFlow Helps You Research Dendritic Cells in Atherosclerosis

Discover & Search

Research Agent uses citationGraph on Hansson et al. (2002; 1023 citations) to map innate-adaptive immunity papers, then findSimilarPapers reveals DC-monocyte links in Tacke et al. (2007) and Świrski et al. (2007). exaSearch queries 'dendritic cell depletion atherosclerosis plaques' for 50+ targeted results from 250M+ OpenAlex papers.

Analyze & Verify

Analysis Agent runs readPaperContent on Frostegård (2013) to extract DC-cytokine data, then verifyResponse with CoVe cross-checks claims against Tabas et al. (2007). runPythonAnalysis processes plaque monocyte counts from Świrski et al. (2007) using pandas for statistical verification; GRADE assigns high evidence to DC-T cell mechanisms.

Synthesize & Write

Synthesis Agent detects gaps in DC subset therapies from Hansson et al. (2002) and Tabas et al. (2015), flags contradictions in monocyte-DC origins. Writing Agent applies latexEditText for figure captions, latexSyncCitations for 10-paper bibliography, latexCompile for review draft; exportMermaid diagrams DC migration pathways.

Use Cases

"Analyze monocyte-DC differentiation data from hypercholesterolemia mouse models"

Research Agent → searchPapers 'Ly6Chi monocytes dendritic cells atherosclerosis' → Analysis Agent → runPythonAnalysis (pandas plots of subset frequencies from Świrski et al. 2007) → statistical summary with p-values and GRADE B evidence.

"Draft LaTeX review on DC antigen presentation in plaques"

Synthesis Agent → gap detection across Tacke et al. 2007 and Hansson et al. 2002 → Writing Agent → latexEditText (intro section), latexSyncCitations (15 refs), latexCompile → camera-ready PDF with plaque inflammation diagram.

"Find code for DC tracking simulations in vascular models"

Research Agent → paperExtractUrls from Tabas et al. 2015 → Code Discovery → paperFindGithubRepo → githubRepoInspect → runnable Python scripts for chemokine modeling with NumPy visualization.

Automated Workflows

Deep Research workflow scans 50+ atherosclerosis immunity papers via searchPapers → citationGraph → structured report on DC roles with GRADE scores. DeepScan applies 7-step CoVe to verify Tacke et al. (2007) monocyte claims against human datasets. Theorizer generates hypotheses on DC-targeted therapies from Frostegård (2013) + recent signaling papers.

Try Doxa for Dendritic Cells in Atherosclerosis Research

Frequently Asked Questions

What defines dendritic cells in atherosclerosis?

Dendritic cells are plaque-resident antigen presenters that mature upon lipoprotein uptake and activate T cells via MHC-II, bridging innate and adaptive responses (Hansson et al., 2002).

What methods study DC function in plaques?

Researchers use CCR2/CX3CR1 flow cytometry for recruitment, DC depletion via clodronate liposomes, and intravital imaging for migration (Tacke et al., 2007; Świrski et al., 2007).

What are key papers on this topic?

Foundational works include Hansson et al. (2002; Circulation Research, 1023 citations) on immunity in atherogenesis and Tacke et al. (2007; JCI, 1289 citations) on monocyte-chemokine roles relevant to DCs.

What open problems exist?

Unresolved issues include human DC subset atherogenicity, antigen specificity in plaques, and safe depletion strategies without broad immunosuppression (Frostegård, 2013).